Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

HSR Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

Quality of HIV care within the Veterans Affairs Health System: A comparison using outcomes from the HIV Cost and Services Utilization Study (HCSUS)

Korthuis PT, Anaya HD, Bozzette SA, Brinkerhoff CV, Mancewicz M, Wang M, Asch SM. Quality of HIV care within the Veterans Affairs Health System: A comparison using outcomes from the HIV Cost and Services Utilization Study (HCSUS). Journal of clinical outcomes management : JCOM. 2004 Dec 1; 11(12):765-774.

Related HSR&D Project(s)

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.
   Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions


Objectives: To assess the quality of care HIV-infected veterans receive through the Veterans Affairs (VA) health care system. Design: Cross-sectional analysis of 2 cohort studies using medical record review. Setting and participants: 3840 HIV-infected veterans receiving medical care in 2001 and 2002 at 16 VA facilities and 1874 participants in the HIV Cost and Services Utilization Study (HCSUS). Main outcome measures: Quality indicators were measured as the percentage of eligible persons receiving highly active antiretroviral therapy (HAART); prophylaxis for Pneumocystis carinii pneumonia (PCP) and Mycobacterium avium complex (MAC); and screening for syphilis, toxoplasmosis, hepatitis A, B, and C infection, and dyslipidemia. Results: 78% of eligible veterans received HAART, 65% received prophylaxis for PCP, and 99% received prophylaxis for MAC. Eligible veterans were screened for toxoplasmosis (44%), syphilis (74%), hepatitis A (55%), B (67%), and C (75%), and dyslipidemia (67%). In adjusted models, persons with intravenous drug use had lower odds of receiving HAART (odds ratio [OR], 0.61 [95% confidence interval {CI}, 0.43-0.87]) than men who have sex with men. Veterans with fewer than 3 visits had lower odds of receiving HAART (OR, 0.08 [95% CI, 0.03-0.20]) and PCP prophylaxis (OR, 0.22 [95% CI, 0.11-0.44). Compared to HCSUS, the VA facilities delivered indicated care in 4 of 5 indicators common to both data sets at a higher rate. Conclusions: Quality of care for HIV-infected veterans was similar to national benchmarks, although a need for improvement was clear in both samples. Interventions to close gaps in quality of HIV care are indicated, particularly for persons with intravenous drug use and those with less than 3 visits per year.

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.